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Abstract Bacteriophages are bacterial viruses that infect the
host after successful receptor recognition and adsorption to the
cell surface. The irreversible adherence followed by genome
material ejection into host cell cytoplasm must be preceded by
the passage of diverse carbohydrate barriers such as capsule
polysaccharides (CPSs), O-polysaccharide chains of lipopoly-
saccharide (LPS) molecules, extracellular polysaccharides
(EPSs) forming biofilm matrix, and peptidoglycan (PG)
layers. For that purpose, bacteriophages are equipped with
various virion-associated carbohydrate active enzymes,
termed polysaccharide depolymerases and lysins, that recog-
nize, bind, and degrade the polysaccharide compounds. We
discuss the existing diversity in structural locations, variable
architectures, enzymatic specificities, and evolutionary as-
pects of polysaccharide depolymerases and virion-associated
lysins (VALs) and illustrate how these aspects can correlate
with the host spectrum. In addition, we present methods that
can be used for activity determination and the application
potential of these enzymes as antibacterials, antivirulence
agents, and diagnostic tools.
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Introduction
Bacteriophages (phages) are bacterial predators. Every phage
infection is initiated by adsorption (i.e., the attachment of the
phage particle to the bacterial host cell), which is characterized
by the specific recognition of a receptor located on the bacterial
cell surface. Subsequently, phages have to penetrate the bacterial
cell envelope andwill eventually eject their viral genome into the
cytoplasm (Weinbauer 2004). On the way to the bacterial cyto-
plasm, phages have to overcome different carbohydrate barriers.
Some bacteria produce capsular polysaccharides (CPSs; also
called K-antigens), which are tightly attached to the cell. Other
bacteria secrete slime with extracellular polysaccharides (EPSs)
to the environment during biofilm formation (Schmid et al.
2015). Both CPS and EPS have a huge diversity in composition,
not only within a bacterial genus but also within a species, and
this composition can also vary dependent on the growth phase
and environmental conditions (Corbett and Roberts 2008;
Leiman and Molineux 2008). Gram-negative bacteria are char-
acterized by an outer membrane composed of lipopolysaccharide
(LPS) molecules with a highly variable O-polysaccharide (O-
antigen), whereas Gram-positive bacteria have essential compo-
nents such as (lipo)teichoic acids embedded in peptidoglycan
(PG). These polysaccharides are often a primary receptor, along
with other protruding cell wall structures such as pili and flagella.
Bacteriophages have evolved various virion-associated carbohy-
drate active enzymes, termed polysaccharide depolymerases, that
recognize, bind, and degrade the polysaccharide compounds to
gain access to the initially inaccessible bacterial cell surface re-
ceptor (Leiman et al. 2007; Leiman andMolineux 2008; Li et al.
2016). This secondary receptor (co-receptor) can be an outer
membrane protein, a cell wall embedded protein (structural pro-
teins, transport channels, enzymatic and secreting proteins), or a
distal part of the exopolysaccharides (Nilsson et al. 2000;
Bertozzi Silva et al. 2016). Binding of this receptor will
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eventually trigger DNA ejection (Leiman and Molineux 2008).
To transfer the genome to the bacterial cytoplasm, bacteriophages
have to overcome another rigid carbohydrate barrier, i.e., the PG.
This structure comprises up to 40 layers in case of Gram-positive
bacteria and 1–3 layers in case of Gram-negative bacteria.
Whereas the chemotype of the PG of Gram-negative bacteria is
conserved (A1γ), the PG composition of Gram-positive bacteria
varies significantly in peptide composition, cross-link, and mod-
ification of the glycan chain (Briers et al. 2007b). Therefore,
phage particles are equipped with a virion-associated lysin. In
contrast to the lysis phase where PG is extensively degraded by
endolysins, the virion-associated lysins only locally puncture a
hole in the PG,which is sufficiently large to eject the phageDNA
into the cytoplasm.
This review gives an overview about the recent knowledge
of virion-associated carbohydrate active enzymes. Whereas
virion-associated lysins are a prerequisite for every phage as
PG is an inevitable barrier, polysaccharide depolymerases pro-
vide the phages with tools to have a competitive advantage in
niches (e.g., in biofilms, these enzymes allow to gain access to
the microcolonies and to infect embedded bacteria (Abedon
2012) and to differentiate in host spectrum). The study on
LPS-degrading depolymerase suggested that the low enzyme
kinetics may be correlated with O-chain degradation impor-
tant for detachment of released progeny, rather than for initial
adsorption step (Steinbacher et al. 1996). Both groups of car-
bohydrate active enzyme share common features such as a
customized enzyme specificity evolved throughout a continu-
ous arm race between phage and host and their structural lo-
cation. Some reviews dealing with these phage-encoded,
virion-associated enzymes have been published recently, par-
ticularly focusing on general characteristics and biomedical
applications (Drulis-Kawa et al. 2012, 2015; Yan et al.
2014) or on virion-associated peptidoglycan hydrolases
(VAPGHs) (Rodríguez-Rubio et al. 2013a). Pires et al.
(2016) recently provided an overview of 160 putative
depolymerases in 143 phages infecting 24 genera of bacteria
based on an extensive in silico analysis. Here, we present a
summary of experimentally confirmed polysaccharide
depolymerases and virion-associated lysins (VALs) and focus
on the main characteristics of the corresponding genes, their
protein structure, their location within the virion particle, their
mode of action and specificity, evolutionary aspects, methods
for activity determination, and potential applications.
Polysaccharide depolymerases
The hallmark feature for the presence of phage-encoded poly-
saccharide depolymerases was firstly described in 1956 as the
plaque-surrounding halos, which increase in diameter over
time of incubation while the plaque size remains constant.
The depolymerases responsible for the degradation of CPS,
EPS, or O-polysaccharide can be virion-associated as an inte-
gral part of the virion particle or can be in a soluble form,
being released during bacterial cell lysis without being inte-
grated in a phage particle (Adams and Park 1956; Stirm et al.
1971). Both can freely diffuse and cause a time-dependent
polysaccharide degradation resulting in the typical halo-like
appearance around plaques. In spite of polysaccharide degra-
dation, phages do not establish an infection since the bacterial
cells in the halo are not actively propagating.
Enzymatic activity and specificity of polysaccharide
depolymerases
Bacteriophage-encoded depolymerases can be divided into
two main classes according to their mechanism of action,
i.e., hydrolases (EC 3) and lyases (EC 4), both resulting in
the cleavage of polysaccharides into soluble oligosaccharides
and the breakdown of the carbohydrate barrier. Within both
classes, there is a tremendous variation in specificity
responding to the large existing diversity in bacterial polysac-
charides (CPS, EPS, O-polysaccharides). This high specificity
usually contributes to the narrow host spectrum. The majority
of hydrolases belong to the group of O-glycosyl hydrolases
(EC 3.2.1), which use a water molecule to cleave specifically
the O-glycosidic bonds of the polysaccharide. This group
comprises sialidases, rhamnosidases, levanases, xylanases,
and dextranases (Davies and Henrissat 1995; Pires et al.
2016). Polysaccharide depolymerases for which experimental
data are available are mainly derived from phages propagating
on the most common human pathogens (Table 1).
Probably, the best studied depolymerases are the sialidases or
endo-N-acetylneuraminidases originating from Escherichia coli
K1 specific bacteriophages such as K1A, K1E, K1F, K1–5, 63D,
CUS-3, Φ1.2, and Φ92 (Kwiatkowski et al. 1983; Petter and
Vimr 1993; Gerardy-Schahn et al. 1995; Long et al. 1995;
Machida et al. 2000; Scholl et al. 2001; Muhlenhoff et al.
2003; Stummeyer et al. 2005; Stummeyer et al. 2006;
Jakobsson et al. 2007; Schwarzer et al. 2012). Sialidases hydro-
lyze internal α-2,8-linkages in capsular polysialic acid. Proteins
possessing endosialidase domains have also been found in
Klebsiella phages KLPN1 and 0507-KN2–1 (Hsu et al. 2013;
Hoyles et al. 2015) (Table 1). Rhamnosidases are enzymes able
to cleave the α-1,3 O-glycosidic bond between L-rhamnose and
D-galactose present in the O-antigen of Salmonella LPS. They
have been described as tailspikes in phages specific for
Salmonella (P27, KB1, P22, 9NA, Det7, Epsilon15) and
Shigella (Sf6) (Wollin et al. 1981; Steinbacher et al. 1996,
1997; Baxa et al. 1996; Chua et al. 1999; Freiberg et al. 2003;
Walter et al. 2008; Chang et al. 2010; Guichard et al. 2013).
E. coli LPS-degrading enzymes were found as endo-N-
acetylglucosaminidase and endo-α-1,3-mannosidase in HK620
and Omega8 phages, respectively (Barbirz et al. 2008; Prehm
and Jann 1976) (Table 1). A levanase catalyzes hydrolysis of
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the β-2,6-bond between fructose monomers in levan, which is
present in Bacillus biofilms and has been identified in Bacillus
phage SP10. A xylanase responsible for hydrolysis of the β-1,4
bonds within xylan has been identified in theCaulobacter phage
Cr30, while a dextranase cleaving the α-1,6-linkages between
glucose units in dextran is predicted in Lactobacillus phage
ΦPYB5 (Pires et al. 2016). Some virion-associated
depolymerases do not depolymerize polysaccharides but cleave
polypeptides (EC 3.4) or lipids (EC 3.1), responding to the dif-
ferent nature of some bacterial capsules. A peptidase enzyme
digesting the poly-γ-glutamate capsular polypeptide of Bacillus
sp. has been experimentally verified for Bacillus phage ΦNIT1
(Kimura and Itoh 2003). Pires et al. (2016) predicted also virion-
associated lipases (triacylglycerol hydrolases) in eight
Cellulophaga phages and one Pseudomonas phage, but experi-
mental validation is currently lacking. A last group of virion-
associated depolymerases with hydrolytic activity are LPS
deacetylases in the tailspikes of the Vi phages (II and III) as well
as those from Salmonella anatum phage c341, which deacetylate
the O-antigen rather than breaking the polysaccharide chain
(Iwashita and Kanegasaki 1976b).
Other polysaccharide depolymerases belong to the class of
lyases, which differentiate from hydrolases as they cleave a
glycosidic bond by β-elimination with the concomitant intro-
duction of new double bond and without the use of a water
molecule. Precisely, this group covers widespread
hyaluronate, pectate/pectin, and alginate lyases and the specif-
ic K5 lyase (Sutherland 1995). Bacteriophage-encoded hyal-
uronidases (hyaluronate lyases) cleave the β-1,4 bonds be-
tween the subunits of hyaluronic acid and were found in pro-
phages invading Streptococcus pyogenes and S. equi, which
are both encapsulated by hyaluronic acid (Hynes et al. 1995;
Ferretti et al. 2001; Baker et al. 2002; Smith et al. 2005;
Mishra et al. 2006; Martinez-Fleites et al. 2009; Lindsay
et al. 2009) (Table 1). Those enzymes are also used by the
lysogenic host bacterium as a virulence factor to invade and
penetrate human tissues. Pectate/pectin lyases are character-
ized by cleavage of the α-1,4 bonds of polygalacturonic acid.
Enzymes possessing such domain have been described for
Pseudomonas phages Φ15 and AF (Cornelissen et al. 2011,
2012), Klebsiella phages (NTUH-K2044-K1–1, KP36) (Lin
et al. 2014; Majkowska-Skrobek et al. 2016), Vibrio phage
JA1 (Linnerborg et al. 2001), and Staphylococcus phage
vB_SepiS-ΦIPLA7 (Gutierrez et al. 2015) (Table 1).
Alginate lyases (mannuronate or guluronate lyases) character-
istic for Pseudomonas and Azobacter phages (PT6) are able to
degrade the α-1,4 bond of alginate, a linear polysaccharide of
β-D-mannuronate, and its C5 epimer α-L-guluronate com-
mon for mucoid strains infecting cystic fibrosis patients
(Davidson et al. 1977; Wong et al. 2000; Glonti et al. 2010)
(Table 1). The E. coliK5 capsular polysaccharide poly(β-1,4-
GlcA-α-1,4-GlcNAc) is a receptor of the capsule-specific bac-
teriophages K5A and K1–5 that both produce a specific lyase
acting on the α-1,4 bond (Clarke et al. 2000; Thompson et al.
2010).
Conserved structural features of polysaccharide
depolymerases
In spite of the large diversity in enzymatic specificity,
depolymerases share strikingly common structural features.
Depolymerases described and characterized to date are present
in the phage virion within tail fibers or tailspikes on the base-
plate, regardless of the phage family they originate from or the
host bacterial species they infect (Table 1). One described
exception is the depolymerase encoded by Staphylococcus
phage vB_SepiS-ΦIPLA7, which shows 99% homology with
a pre-neck appendage protein (Gutierrez et al. 2015).
Generally, depolymerases form elongated homotrimers that
appear as protruding cell-puncturing devices on the virion,
which aligns well with their biological function. The
endosialidase encoded by E. coli siphophage 63D, however,
was characterized as a homotetramer (Machida et al. 2000).
On the structural level, depolymerases are fibrous proteins
with a parallel β-helix topology composed of parallel β-
strands orthogonal to the long axis (Fig. 1). This protruding
shape extends the active site to recognize and bind specific
sequences buried within cell surface polysaccharides (Weigele
et al. 2003). The P22 tailspike with rhamnosidase activity
degrading the LPS O-polysaccharide of Salmonella
typhimurium binds its substrate along its entire length
(Steinbacher et al. 1996). Therefore, the protruding shape of
phage-encoded polysaccharide depolymerases has been pro-
posed to create a long lateral surface for reading the specific
polysaccharide sequence, determining the host specificity
(Bradley et al. 2001). The complex structure of highly inter-
woven β-sheets also determines the high stability of these
proteins, since they were found to be resistant to high temper-
ature (possessing relatively high melting point temperature),
proteases, and detergents at room temperature. This high sta-
bility corresponds to the harsh external conditions these pro-
teins have to withstand in different environments such as the
presence of proteases and denaturing conditions (Yan et al.
2014; Majkowska-Skrobek et al. 2016).
Phage-encoded polysaccharide depolymerases
in evolution
Due to the intimate co-evolution between phages and their
bacterial hosts, polysaccharide diversity implies correspond-
ing tail fiber and tailspike diversity. The highest level of di-
versity and mosaicism among phages within the operon of
genes encoding structural proteins can be seen in the genes
encoding receptor binding proteins (RBPs), reflecting the in-
volvement of intensive vertical and horizontal transfer in the
evolution of these proteins (Casjens and Molineux 2012). A
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common architecture of RBPs (including polysaccharide
depolymerases) consists of three domains (Fig. 1). A small
N-terminal domain is responsible for flexible connection of
the RBP to the tail structure or to the baseplate. A large central
domain forming the elongated homotrimeric structure is the
key domain for host recognition and in the case of
depolymerases possesses the enzymatic activity. The C-
terminal domain seems to be responsible for protein
trimerization and mainly works as an intra-molecular chaper-
one, while others also assign a function of receptor recognition
to this domain (Weigele et al. 2003; Cornelissen et al. 2011;
Schwarzer et al. 2012; Yan et al. 2014). The N-terminal as
well as C-terminal domains of RBPs are conserved among
phages belonging to the same group, while the host-specific
central domain is highly variable and can be changed to mod-
ulate host range or to adapt to a new environment (Stummeyer
et al. 2006; Schwarzer et al. 2012). Two different strategies of
phages to adapt their RBPs to the polysaccharide receptor
while conserving the same motif fold have been described:
(1) changing the active site residues by mutation (vertical
transfer) and (2) swapping with complete foreign domains
specific for a different polysaccharide (horizontal transfer)
(Barbirz et al. 2008; Leiman and Molineux 2008).
In the first strategy, many mutations are acceptable in the
central domain as far as the stacking interactions between β-
helix rungs remain intact (Leiman and Molineux 2008). This
evolution can be observed between the homotrimeric
tailspike of phage HK620, specific for E. coli O18A1, and
similar tailspikes of phages P22 and Sf6 infecting
Salmonella (Barbirz et al. 2008) (Table 1). Specifically, the
active site residues involved are located on loops protruding
from the β-helix structure, and thus, mutations therein do not
affect the β-helix conformation. Two phages (HK620 and
P22) do bind the polysaccharide between two protruding
loops of the same monomer within the homotrimer (i.e.,
intra-subunit substrate binding), while in the case of phage
Sf6, the polysaccharide binding site is located inter-subunit.
These differences highlight the phage versatility to adjust the
same protein fold to various substrates bymutation in different
ways.
The second strategy is based on the exchange of complete
tailspike modules to gain different specificity accordingly.
This is clearly exemplified by the conserved N-terminal do-
main among the tailspikes of phages CUS-3, HK620, Sf6, and
P22, while the catalytic domain of CUS-3 (i.e., an
endosialidase, being specific for the E. coliK1 antigen) differs
completely from the catalytic domain of the three others
(Table 1). Moreover, the tailspike of phage K1F comprises
the same catalytic domain as CUS-3 but shares the N-
terminal domain of the T7 tail fiber (Stummeyer et al. 2006).
These relationships clearly demonstrate evolution through
horizontal transfer. A different, more complex configuration
of tailspikes are the RBPs of podoviruses K1E, K1–5, and
SP6. These viruses produce a specific adapter protein respon-
sible for connection of the host-specific depolymerases to the
virion. This adapter protein is equivalent in its function to the
N-terminal domain of the tailspikes of CUS-3, HK620, Sf6,
and P22 but is a larger, separate protein that provides the
attachment site for two tailspikes, each with a different poly-
saccharide specificity. Tailspikes are interacting with the
adapter protein by a short, conserved, N-terminal peptide
(Leiman et al. 2007). Specifically, both phages K1E and
K1–5 possess tailspikes with endosialidase activity specific
for the K1 antigen. Phage K1–5 is equipped additionally with
the K5 lyase enabling recognition of the K5 antigen (Scholl
et al. 2001) (Table 1). Phage K1–5 has thus a dual specificity
and can infect both K1 and K5 strains. Interestingly, the K1E
has a small and probably truncated protein without enzymatic
activity as the second tailspike and has therefore a more
narrow host spectrum. Clarke et al. (2000) have proposed that
phage K1E has evolved from phage K5A by the acquisition of
the gene encoding the tailspike with endosialidase activity and
the subsequent loss of the K5 lyase by a kflA gene truncation.
Fig. 1 Structural architecture of phage tailspike/depolymerase on the
base of P22 tailspike (PDB ID 1LKT and 1TYV; JavaScript Protein
Viewer). N-terminal dome-like structure domain (a). Central domain for
host recognition and enzymatic activity (b). C-terminal domain
responsible for protein trimerization or/and receptor recognition (c)
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Salmonella phage SP6 is morphologically and biologically
similar to phages K1E and K1–5, but the catalytic domain of
the tailspike is homologous to Salmonella phage P22
tailspikes with rhamnosidase activity involved in degradation
of the Salmonella O-antigen, explaining the different host
spectrum. At the same time, SP6 has a second but still un-
known enzymatically active tailspike that broadens the host
range to rough and smooth Salmonella strains, in contrary to
phage P22 that infects only the smooth type (Scholl et al.
2002, 2004). E. coli bacteriophage Φ92 isolated in 1983 was
reinvestigated by Schwarzer et al. (2012). Apart from the
original host E. coli K92, which possesses a polysialic acid
capsule, they found that this myovirus is also able to infect
non-encapsulated E. coli laboratory strains such as EV5, a
capsule defective derivative of a K1 strain; K-12 and B strains;
and Salmonella strains (Kwiatkowski et al. 1983; Vimr and
Troy 1985; Schwarzer et al. 2012) (Table 1). A cryoEM anal-
ysis of the Φ92 virion showed the presence of a multivalent
host adsorption apparatus with at least five different receptor
binding proteins being tailspikes or tail fibers. Moreover, the
closely related phage PVP-SE1 encodes even six different tail
fibers and spikes (Santos et al. 2011; Schwarzer et al. 2012).
The best depolymerase-equipped phage is a recently described
Klebsiella phage ФK64–1 (Pan et al. 2015, 2017) (Table 1).
This giant virus was found to be able to propagate on a broad
range of Klebsiella strains, with representatives of up to ten
serotypes. ФK64–1 possess 11 genes encoding tail fibers,
tailspikes, or lyases. Each expressed protein (S2–4, S1–1,
S1–3, S2–2, S2–6, S2–3, S2–5, S1–2, S2–1) has activity spe-
cific to a different capsular polysaccharide (K1, K11, K21,
K25, K30/K69, K35, K64, KN4, and KN5, respectively).
Moreover, two proteins (S2–7 and S2–8) were not found ac-
tive against any capsular serotype known until now (Pan et al.
2017). The electron micrographs of this giant phage revealed
similar morphology to phage vB_KleM-RaK2 with broom-
like tail fibers and several spike-like structures. Such high
variety cannot be achieved in small bacteriophages belonging
to Podoviridae family, which have a small tail, but is more
likely in larger myoviruses.
Methods for depolymerase activity determination
Determination of the depolymerizing activity is particularly chal-
lenging, as the difficulties to separate CPS/EPS or biofilmmatrix
from LPS complicate the analysis of polysaccharide degradation.
As a consequence, the methods used so far are highly diverse but
can generally be subdivided in biological, biochemical, and
physical methods that can be either used generally independent
of the polysaccharide structure and composition or used for spe-
cific substrates. The primary biological way to detect the pres-
ence of depolymerases is the application of spots of phages/
enzyme on bacterial lawns and screening for the typical turbid
halos (Cornelissen et al. 2011). Spectrophotometric methods
allow a more quantitative determination of the depolymerase
activity. For the evaluation of biofilm matrix degradation, a stan-
dard crystal violet or dimethyl methylene blue (DMMB) dye can
be used to quantify biofilm matrix colorimetrically (Cornelissen
et al. 2011, 2012; Tote et al. 2008). Spectrometric measurement
of reducing sugars allows to determine the EPS/CPS digestion
(Yurewicz et al. 1971; Rieger et al. 1975; Hsu et al. 2013). Other
methods include examination of periodate oxidation of saccha-
rides by determining the consumption of sodium periodate and
the amount of formic acid formed (Kwiatkowski et al. 1983),
evaluation of decrease of turbidity of insoluble EPS precipitated
by cetylpyridinium chloride (CPC complexes) (Born et al. 2014;
Majkowska-Skrobek et al. 2016), or uronic acid release (Glonti
et al. 2010). Also, the crude separation of released sugars from
polymer was analyzed by TLC chromatography (Glonti et al.
2010). Rheological analyses of alginate gels were done to mea-
sure the diffusion rate of phages through exopolysaccharides, as
well as viscosity reduction measurements of treated polysaccha-
rides (Thurow et al. 1974; Hanlon et al. 2001; Glonti et al. 2010).
A couple of electrophoretic methods were also implemented to
analyze depolymerase activity. The non-digested and digested
polysaccharides can be compared on polyacrylamide gel electro-
phoresis (PAGE/SDS PAGE) stained by alcian blue/silver/meth-
ylene blue (Clarke et al. 2000; Barbirz et al. 2008; Majkowska-
Skrobek et al. 2016). Fluorophore-assisted carbohydrate electro-
phoresis (FACE) (Chua et al. 1999) and capillary electrophoresis
(Baker et al. 2002) are other electrophoretic methods that have
been used. For more detailed analysis of the cleavage specificity,
the lists of biochemistry techniques were implemented, such as
1H NMR spectroscopy, FABMS, MALDI MS, GC MS, ESI-
MS, and EIMS (Thurow et al. 1974; Linnerborg et al. 2001).
There is also the possibility to measure biofilm thickness by
confocal laser scanning microscopy (CLSM) (Cerca et al.
2012), scanning electron microscopy (SEM), or atomic force
microscopy (Chatterjee et al. 2014). A fully electric tuning fork
resonance frequency measurement system designed by Piasecki
et al. (2015) offered an effective mass measurement in a novel
approach to evaluate the bacterial biofilm parameters such as
mass, viscosity, and density. One of the more sophisticated tech-
niques enabling precise measurement of biofilm matrix degrada-
tion is the laser interferometry detecting the small-molecule dif-
fusion rate trough biofilm layer (Danis-Wlodarczyk et al. 2015,
2016).
Applications of polysaccharide depolymerases
The unique ability of phage-derived depolymerases to specifical-
ly recognize and degrade CPS, EPS, and the O-antigen offers an
attractive and promising tool for controlling pathogenic bacteria
and other applications, including clinical diagnostics and bio-
chemical analyses. Although most of these proteins do not seem
to possess bactericidal activity as described for VALs and
endolysins, they should be considered in therapy for their
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antivirulent potential (Majkowska-Skrobek et al. 2016). The loss
or modification of bacterial surface structures that are used by
many pathogens to promote virulence, host colonization, and
biofilm formation makes bacteria less pathogenic and/or sensi-
tizes them to either some antimicrobials or host defenses such as
phagocytosis by macrophages and the bactericidal action of se-
rum (Mushtaq et al. 2004, 2005; Zelmer et al. 2010; Bansal et al.
2014; Pan et al. 2015). Therapeutic efficacy of recombinant
depolymerases that only modify the phenotype of the bacterial
cells without affecting their viability and growth rate has been
confirmed in animal models (Mushtaq et al. 2004; Waseh et al.
2010; Pan et al. 2015; Majkowska-Skrobek et al. 2016). When
phage K1E endosialidase (endoNE) is administered intraperito-
neally to neonatal rats infected with neuroinvasive E. coli K1
strains, a significant reduction of mortality due to bacteremia
and the life-threatening systemic infection was observed
(Mushtaq et al. 2004, 2005; Zelmer et al. 2010). In another study,
the oral administration of Salmonella-specific endorhamnosidase
from P22 phage (P22sTsp) to chickens prevented the pathogen’s
colonization of the gut and its penetration into internal organs
(Waseh et al. 2010). An interesting approach is the idea of algi-
nate lyase application as an antibiofilm agent in combating
Pseudomonas aeruginosa biofilm in the airways of cystic fibro-
sis patients (Glonti et al. 2010). Degradation of alginate, the
exopolysaccharide produced by mucoid P. aeruginosa strains,
can remove a barrier that protects bacterial cells from macro-
phages in the lungs, can perturb bacterial growth in biofilms,
and decreases the viscosity of sputum (Hanlon et al. 2001;
Glonti et al. 2010). Depolymerase-mediated biocontrol of path-
ogens has also been successfully attempted in a pathogen-plant
system. Effective enzyme application has been observed in trans-
genic pears and apples that express the EPS-degrading enzyme
fromΦEa1h phage, conferring resistance to fire blight caused by
Erwinia amylovora (Malnoy et al. 2005; Flachowsky et al.
2008). An important challenge is the creation of depolymerases
with lytic activity. A study carried out by Scholl et al. (2009)
revealed that a recombinant fusion protein between the
endorhamnosidase-active tailspike protein from E. coli O157-
specific phage ΦV10 and a R-type pyocin is able to lyse
E. coli O157:H7 strains and can be applied to eliminate the
pathogen from food.
Phages able to express several depolymerases can also be
constructed by synthetic biology (Lu and Collins 2007;
Azeredo and Sutherland 2008). Potentially, in comparison to
phages currently used in therapy, these genetically modified
phages with a broader range of activities would bemore effective
or even target other serotypes. Depolymerases could also be
applied in combination with conventional antimicrobials against
multidrug-resistant pathogens, notably those living in biofilm
communities. The synergistic action of either phages producing
depolymerase or recombinant depolymerase with conventional
chemical agents, including antibiotics and disinfectants, have
already been shown to suppress Klebsiella infections (Verma
et al. 2009, 2010; Bansal et al. 2014; Chai et al. 2014).
Moreover, the ability of phages to express not only their own
but also other bacterial enzymes indicates their potential to spe-
cifically target pathogens possessing for example chondroitin
capsules (Cress et al. 2014). Besides combating bacterial infec-
tions, depolymerases can be used as an alternative to antiserum
for the typing of bacterial strains and the detection of polysac-
charides in immunohistological studies. The first test of this con-
cept was initially realized with Klebsiella strains. Owing to the
high specificity of depolymerases, it was suggested that enzyme-
based capsular typing may be more useful than whole phage
typing (Hsu et al. 2013; Lin et al. 2014). The analogous approach
has been successfully applied to develop an endosialidase-based
detection reagent for identification of polysialic acid-containing
bacteria as well as eukaryotic cells (Jakobsson et al. 2015). As a
detection tool, these enzymes are used in a catalytically inactive
form, capable to recognize and bind the substrate, but without its
degradation. Their potential advantages that give them the su-
premacy over antibodies are (i) the production based on recom-
binant technology without the use of animals, (ii) the lack of
cross-reactivity with cell surface proteins, and (iii) the lack of
toxicity. It is also worth noting that endosialidases, besides ther-
apeutic and diagnostic significance, are also of interest as tool to
degrade artificial polysialic acid-based hydrogels and other de-
rivatives used as a scaffold biomaterial in neurobiology (Berski
et al. 2008).
Virion-associated lysins
VALs are generally linked to a component of the virion and
therefore are also known as VAPGHs (Rodríguez-Rubio et al.
2013a), tail-associated muralytic enzymes (TAMEs) (Paul et al.
2011), and structural lysins or exolysins (Oliveira et al. 2013).
However, all these names are confusing. First of all, some VALs
are in fact lytic transglycosylases, which are not hydrolases.
Secondly, the phage tail is the most common attachment site
for VALs, but not the only one. VAL can also be anchored to
the phage neck, baseplate, or can be embedded in the viral mem-
brane. Thirdly, some VALs do not serve as structural elements
but are connected to the genomic phage DNA or occur as free
form enclosed in the capsid (Table 2). Finally, exolysins are
generally associated with enzymes secreted by a bacterium to
kill competing bacteria. For these reasons, virion-associated lysin
is the most appropriate name and is used in this review.
Enzymatic mechanism of action and specificity of VALs
Based on the type of the chemical bond that is cleaved, the
specificity of VALs is classified into three categories: (i) glyco-
sidases, further subdivided into lysozymes, glucosaminidases,
and lytic transglycosylases, cleaving one of the two glycosidic
bonds in the glycan chain; (ii) amidases cutting the amide bond
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between the lactyl group of N-acetylmuramic acid and L-alanine
of the stem peptide; and (iii) endopeptidases cleaving within the
stem peptide or the cross-link (Young 1992). The vast majority of
described VALs, including the best studied examples from coli-
phages T4 (Gp5—lysozyme) and T7 (Gp16—lytic
transglycosylase) (Yap and Rossmann 2014; Moak and
Molineux 2000) are glycosidases (Table 2), and technically, only
those enzymes are carbohydrate active enzymes. Lysozymes and
lytic transglycosylases cleave the same β-1,4-glycosidic linkage
between N-acetylmuramic acid and N-acetyl-D-glucosamine.
However, lytic transglycosylases are not hydrolases like lyso-
zymes as they do not use a water molecule during cleavage but
instead catalyze the concomitant formation of a 1,6-
anydromuramoyl product (Scheurwater et al. 2008).
Endopeptidase activity is generally attributed to VALs of
Gram-positive-specific phages such as ORF56, Gp44,
Tal(2009), and Tal(901–1) and CwlP encoded by phages K,
Φ11, Tuc2009, TP901–1, and SP-β, respectively (Sudiarta
et al. 2010; Paul et al. 2011; Stockdale et al. 2013) (Table 2).
Only one VAL originating from a Gram-negative-infecting
phage, specifically Gp5 of Pseudomonas phage Φ6 (dsRNA,
Cystoviridae), has been demonstrated to possess endopeptidase
activity (Caldentey and Bamford 1992). VALs with amidase
activity include Gp61, HydH5, and Gp49 of Staphylococcus-
specific Siphoviridae ΦMR11, ΦIPLA88, and Φ11 (Rashel
et al. 2008; Rodríguez et al. 2011) (Table 2).
Various architectures of VALs
In terms of structure, VALs are highly diverse enzymes.
Differences relate to the number of domains and their organi-
zation, molecular weight, and oligomeric state. The structure
of VALs is modular and reminiscent of the structure of many
polysaccharide depolymerases. It consists of a domain that
binds to the virion and one or two lytic domains responsible
for PG degradation. An additional domain, responsible for cell
wall binding, was found in P17 VAL of staphylococcal phage
P68 (Takác and Bläsi 2005). The majority of VALs possess a
single lytic domain. Only five VALs with two different lytic
domains have been reported for Staphylococcus phages
(Table 2), which are CwlP of prophage SP-β with lysozyme
and endopeptidase domains (Sudiarta et al. 2010), Gp44 of
phageΦ11 with endopeptidase and SGNH hydrolase domains
(Li et al. 2016), Gp61 of phage ΦMR11 (Rashel et al. 2008),
HydH5 of phage ΦIPLA88 (Rodríguez et al. 2011;
Rodríguez-Rubio et al. 2012, 2013b), and Gp49 of phage
Φ11 (Rodríguez-Rubio et al. 2013c; Li et al. 2016), all with
lysozyme and amidase activities. Interestingly, all VALs with
two lytic domains are encoded by phages specific for Gram-
positive bacteria, which may be related with the thick cell wall
of Gram-positive cells (Table 2). The order of VAL domains is
also variable. Lytic active domains can be located at the N-
terminus (e.g., P17 of phage P68, Gp3 of phage Φ29) (MoakTa
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and Molineux 2004; Takác and Bläsi 2005), at the C-terminus
(e.g., Gp36 of phage ΦKMVand Pb2 of phage T5) (Lavigne
et al. 2004; Boulanger et al. 2008), or at both termini of the
protein (e.g., Gp44 and Gp49 of phage Φ11) (Li et al. 2016).
Equally large diversity is observed for the molecular weight of
VALs within the range of 37–252 kDa, with the smallest being
the internal membrane VAL P7 of phage PM2 (Kivelä et al.
2004) and the largest being CwlP of prophage SP-β (Sudiarta
et al. 2010), respectively. The oligomeric state has only been
characterized for a few VALs. They can be present as mono-
mers like the viral membrane-associated Gp5 of phage Φ6
(Caldentey and Bamford 1992) but also as a dodecamer like
Gp4 found in neck of phage P22 (Tang et al. 2011). However,
a trimeric state as found in Gp5, component of the hub of the
T4 phage baseplate (Kanamaru et al. 2002), Tal(2009) and
Tal(901–1) forming the tail tips of phages Tuc2009 and
TP901–1, respectively (Stockdale et al. 2013), is the most
frequently described oligomeric state. It is also worth to men-
t ion that E. coli phage PDR1 (Tectivir idae) and
Staphylococcus phageΦ11 (Siphoviridae) are the only known
examples of bacterial viruses equipped with two different
VALs (Table 2).
Location of VALs in the virion
VALs appear in various parts of the virion. In the case of
Tectiviridae, membrane-containing coliphages like PRD1
(proteins P7 and P15) andΦ6 (Gp5) VALs are associated with
the viral membrane and exposed on the outside of the nucle-
ocapsid surface (Caldentey and Bamford 1992; Rydman and
Bamford 2000, 2002). The phage tail is the most common
location of VALs encoded by Caudovirales, wherein the tail
tip is the most typical location of VALs from Siphoviridae
attacking Gram positives (Table 2). Another location is the
baseplate where VAL oligomers form a cell-puncturing de-
vice. Baseplate location is characteristic for Gp5 of T4 coli-
phage (Kanamaru et al. 2002) and gp181 of Pseudomonas
phage ΦKZ (Briers et al. 2008; Fokine et al. 2008). The Gp4
of the Salmonella-specific phage P22 is the only VAL de-
scribed so far that is located at the phage neck (Tang et al.
2011). The Gp16 encoded by phages T7, T3, and øYeO3–12
and Gp36 of phage SP6 are internal head proteins that form
part of an extensible tail, which is characteristic for most
Gram-negative-specific Podoviridae (Struthers-Schlinke
et al. 2000; Moak and Molineux 2004; Serwer et al. 2008,
2014). Also, Gp3 of phage Φ29 and probably Gp3 of the
similar phages GA-1 and M2 as well are located in the phage
head but are linked to the genomic DNA. VALs of these
Podoviridae infecting Gram-positive Bacillus sp. are ejected
from the virion prior the DNA, allowing efficient infection
(Moak and Molineux 2004). Moreover, it was demonstrated
that a small portion of the free form of Gp3 (not attached to
DNA) is enclosed inside the capsid of phage Φ29 and may
move down to the tail tip, digesting the peptidoglycan together
with the portion of Gp3 that is covalently bound to DNA
(Moak and Molineux 2004).
Methods for activity determination of VALs
As for depolymerases, there is no standard procedure for the
evaluation of the enzymatic activity of VALs. However, the
variability in peptidoglycan composition is lower than the one
of EPS, CPS, and O-polysaccharide, resulting in some more
common practices for which either purified substrates are used
(PG, sugar chains, peptides) or whole cells. These cells can be
either a living or a dead, autoclaved cell suspension. In case of
Gram-negative cells, the outer membrane has to be removed
first to make the PG accessible. Outer membrane perme-
abilization is hereby achieved by chloroform vapor that dis-
solves the lipid inner and outer membranes. The lytic activity
of most described VALs has been demonstrated on purified
PG using in-gel activity staining (zymography) or by spectro-
photometry using whole cells (Caldentey and Bamford 1992;
Kaberdin and McDowall 2003; Moak and Molineux 2004;
Kivelä et al. 2004; Lavigne et al. 2004; Sudiarta et al. 2010;
Briers et al. 2006, 2008; Rodríguez et al. 2011; Stockdale et al.
2013; Rodríguez-Rubio et al. 2012). Both methods imply the
analysis of the reduction in turbidity of the substrate, either as
transparent bands in turbid gels (zymography) or by spectro-
photometry measuring the optical density. The spectrophoto-
metric approach is the most accurate to quantify the enzymatic
(U/ml) or specific (U/mg) activity. It is also commonly used
for endolysin testing and relies on determination of the rate of
reduction of the optical density of a substrate suspension at
600 nm upon addition of a given amount of enzyme
(expressed as ΔOD600/μg min) (Donovan et al. 2006;
Donovan and Foster-Frey 2008; Becker et al. 2009;
Rodríguez-Rubio et al. 2012). The general limitation of this
method is the high Bday-to-day^ variability in the results
(Donovan and Foster-Frey 2008). A standardized approach
for enzymatic activity determination of PG-degrading
endolysins against Gram-negative strains has been proposed
by Briers and co-workers (Briers et al. 2007a) and relies on the
determination of the linear region of the turbidity drop.
Enzymatic activity is expressed in U, often corresponding to
a linear descent in OD600 of 0.001 per min (Cheng et al. 1994).
This method has been used for determination of enzymatic
activity of VALs of phages ΦKMV (Lavigne et al. 2004)
and ΦKZ (Briers et al. 2008). The cleavage specificity of
phages lysins is only rarely experimentally examined and is
often based on in silico homology and therefore biased by
historic misannotations. However, in those few experimental-
ly validated cases, liquid chromatography–mass spectrometry
is the most common method (Caldentey and Bamford 1992;
Sudiarta et al. 2010; Stockdale et al. 2013; Rodríguez-Rubio
et al. 2016; Maciejewska et al. 2017).
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Use of lysins as antibacterial proteins
VALs possess properties that make them potential weapons to
prevent and combat bacterial pathogens. Indeed, purified
VALs kill Gram-positive cells when they are added exoge-
nously as the PG is directly accessible and its breakdown
results in osmotic lysis and immediate cell death. Similar to
the use of endolysins for the same goal, VALs are featured by
(i) high specificity, targeting only a subset of pathogens; (ii)
desirable mode of action on unique and highly conserved
bonds in PG, reducing the risk on fast emergence and spread
of resistance; (iii) lytic and antibacterial activities regardless of
the presence of antibiotic resistance mechanisms; and (iv) ad-
ditional useful features like thermostability, high ionic
strength tolerance, and synergistic activity with antibiotics or
endolysins. The antibacterial activity of VALs against Gram-
positive bacteria mainly focused on Staphylococcus aureus.
The P17 VAL was shown to have a spectrum activity against
most of S. aureus clinical strains, including isolates resistant to
phage P68, the producer of P17 (Takác and Bläsi 2005).
Antistaphylococcal activity was also demonstrated for both
lytic domains of Gp61 of phage ΦMR11, causing lysis of
approximately 80% of S. aureus cells within 30 min (Rashel
et al. 2008). Other VALs lethal to S. aureus are ORF56 of
phage K (Paul et al. 2011) and HydH5 of phage ΦIPLA88,
which were shown to lyse S. aureus (including methicillin-
resistant S. aureus (MRSA)) and S. epidermidis. Moreover,
HydH5 is thermostable up to 100 °C for 5 min and acts syn-
ergistically with endolysin LysH5 (Rodríguez et al. 2011;
Rodríguez-Rubio et al. 2012). Regarding Gram-negative path-
ogens, VALs have been demonstrated to lyse the peptidogly-
can of outer membrane-permeabilized cells. Gp36 of phage
ΦKMV and Gp181 of phage ΦKZ showed lytic activity
against P. aeruginosa with a specific activity of 4800 U/mg
(similar to commercial hen egg white lysozyme) and
60,000 U/mg, respectively (Lavigne et al. 2004; Briers et al.
2006, 2008). Furthermore, Gp36 possesses a highly thermo-
stable, C-terminal lysozyme domain retaining activity after
treatments of at 95 °C, whereas the Gp181 tolerates high ionic
stress (>320 mM) (Briers et al. 2008). Gp5 of Pseudomonas
phage Φ6 is lytic in vitro against several outer membrane-
permeabilized, Gram-negative species (Pseudomonas
phaseolicola, P. aeruginosa, P. fluorescens, P. putida,
E. coli, S. typhimurium, and Proteus vulgaris) (Caldentey
and Bamford 1992). In spite of a natural exogenously acting
function, lysins can generally not penetrate the outer mem-
brane when not associated with the virion. Therefore, recom-
binant lysins can only kill intact Gram-negative bacteria in
presence of outer membrane permeabilizers such as EDTA.
Genetic modification with outer membrane-permeabilizing
peptides as has been described for endolysins in the develop-
ment of artilysins (Briers et al. 2014; Gerstmans et al. 2016)
can be an option. In context of the improvement of the
potential of VALs as antibacterials, different chimeric proteins
comprising one or more domains of lysins have been con-
structed and characterized. P16–17 comprising the N-
terminal endopeptidase domain of the endolysin (P16) and
the C-terminal cell wall binding domain of the VAL (P17) of
Staphylococcus phage 68 shows a high and specific antibac-
terial activity against S. aureus strains. P16–17 acts synergis-
tically with gentamicin and increases bacterial sensitivity to-
wards this drug (Manoharadas et al. 2009). Protein P128, a
chimera of the N-terminal endopeptidase of the structural ly-
sin from staphylococcal K phage and the cell wall-binding
SH3 of lysostaphin, was demonstrated to possess strong
antistaphylococcal activity and was successfully used in de-
colonization of rat nares from staphylococcal infection, reduc-
ing the bacterial load by two orders of magnitude after treat-
ment. Moreover, P128-resistant mutants were shown to lose
the β-lactam drug resistance phenotype and become hyper-
sensitive to β-lactams (Paul et al. 2011; Saravanan et al. 2013;
Sundarrajan et al. 2014). Two other chimeric proteins, i.e.,
HydH5Lyso and HydH5SH3b, were prepared based on the
HydH5 from S. aureus-specific phage ΦIPLA88. The
HydH5Lyso (a fusion of HydH5 with lysostaphin) and
HydH5SH3b (fusion of HydH5 with lysostaphin binding do-
main SH3b) were able to lyse MRSA and S. epidermidis cells
with higher activity than each of the enzymes separately. Both
chimeric proteins have proven their usefulness as effectivemilk
biopreservatives (Rodríguez-Rubio et al. 2012). Another chime-
ric protein composed of the endopeptidase domain of the VAL
and the cell wall binding domain of the endolysin of
Enterococcus faecalis phage F170/08 is the EC300 protein.
The muralytic activity of EC300 showed enhanced activity over
the original lysins against clinical, multidrug resistant E. faecalis
strains (Proença et al. 2015).
In conclusion, phages have evolved elaborate, virion-
associated carbohydrate active enzymes that accommodate
the existing diversity in carbohydrate barriers presented to
phages during infection. This intimate co-evolution with a
high evolutionary rate has provided us with a highly versatile
tool kit of specific proteins to either kill, sensitize, or detect
bacteria.
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